Stephen I. Pelton, MD
Professor
Boston University Chobanian & Avedisian School of Medicine
Pediatrics
Infectious Diseases

MD, State University of New York at Buffalo
BA, Queens College, City University of New York



Stephen I Pelton MD is Professor of Pediatrics and Epidemiology at Chobanian and Avedisian School of Medicine and Public Health and Director of Pediatrics Infectious Diseases at Boston Medical Center. Dr Pelton's interests focus on the effects of recurrent disease and the long term effects of HIV, Hepatitis C and B, and Herpes among other things. Additionally, he organizes numerous clinical trials to discover new approaches to HIV prevention and treatment.

Director (Section) of Pediatrics>Infectious Disease
Boston University Chobanian & Avedisian School of Medicine
Pediatrics
Infectious Diseases

Member
Boston University
Pulmonary Center


Professor
Boston University School of Public Health
Epidemiology




Proposal to evaluate prevalence, serotype distribution and density of pneumococcal nasopharyngeal colonization in children and parents
12/15/2015 - 03/31/2019 (PI)
Pfizer, Inc.


Acute Otitis Media (AOM) Study
08/01/2015 - 12/31/2018 (PI)
Pfizer, Inc.


Defining the new equilibrium of pneumococcal nasopharyngeal colonization following introduction of PCV13
01/01/2013 - 06/30/2017 (PI)
Merck, Sharp & Dohme LLC


Enhanced Surveillance for IPD in Massachusetts Children
01/01/2007 - 06/30/2017 (PI)
Wyeth Pharmaceuticals


Continued Surveillance of IPD in Children Less than 18 Years Old in Massachusetts in 2010-2012 (Impact of the Introduction of PCV13)
11/15/2010 - 11/14/2013 (PI)
Pfizer, Inc.


Carriage Prevalence of NTHi in Mother and Infant Dyads
11/01/2008 - 07/22/2011 (PI)
GlaxoSmithKline LLC


Pedi ID Fellow: International Fellowship in Vaccine Preventable Diseases
05/01/2008 - 04/30/2010 (PI)
Wyeth Pharmaceuticals

Enhanced Surveillance for Meningococcal Disease
04/07/2005 - 04/06/2008 (PI)
Sanofi-Pasteur, SA

NTHi LPS: Virulence Factor and Vaccine Candidate
08/01/2003 - 07/31/2007 (Co-PI)
NIH/National Institute on Deafness & Communication Disorders
5 R01 DC05855 03

Identification of Children with Invasive Pneumococcal Disease in Massachusetts and Immunologic Evaluation of Vaccine Failures
10/01/2001 - 06/30/2005 (PI)
Wyeth-Lederle

Showing 10 of 20 results. Show All Results

Surveillance for invasive pneumococcal disease and otitis media among Kaiser Permanente Southern California Membership from 2021 through 2027 (IPD & OM Study)
04/01/2024 - 08/31/2027 (PI)
Southern California Permanente Medical Group

A Multisite Randomized Trial of Viral Combat: A Mobile Gaming App to Improve Adherence to PrEP
08/17/2022 - 07/31/2027 (PI)
Brown University National Institutes

Surveillance of Pneumococcal Colonization in Children less than 5 years of age at Boston Medical Center
10/15/2021 - 10/14/2026 (PI)
Pfizer, Inc

Surveillance for Invasive Pneumococcal Disease (IPD) and Serotype Replacement in the Ten Years follo
01/01/2020 - 12/31/2025 (PI)
Kaiser Foundation Research Institute Wyeth Pharmaceutical

Surveillance of Invasive Pneumococcal Diseases (IPD) in Massachusetts’ Children - WI245928
12/13/2018 - 12/31/2025 (Multi-PI)
PI: Stephen I. Pelton, MD
Pfizer, Inc

Maternal Fetal Medicine Units Network (MFMU Network)
12/01/2018 - 03/31/2025 (PI)
George Washington University National Institute o

Molecular characterization of virulence factors in an in vitro model of Respiratory Syncytial Virus and Streptococcus pneumoniae co-infection
02/22/2024 - 02/28/2025 (PI)
Merck Sharp & Dohme, LLC

A Prospective Observational Study to Evaluate the Safety of COVID-19 Vaccination in Pregnant Women
12/01/2020 - 09/29/2024 (PI)
Centers for Disease Control and Prevention/DHHS

Why do certain pneumococcal vaccines serotypes persist in the community? Why does replacement invasive pneumococcal disease differ in different geographies?
10/01/2021 - 09/16/2024 (PI)
Merck

Interactions of Streptococcus pneumoniae and Non-typeable Haemophilus influenzae and the developm…
10/01/2019 - 07/31/2024 (PI)
Merck

Showing 10 of 77 results. Show All Results

Title


Yr Title Project-Sub Proj Pubs
2023 "Optical Tympanostomy Tube" for prevention and treatment of tympanostomy tube otorrhea 5R21DC019958-02
2022 "Optical Tympanostomy Tube" for prevention and treatment of tympanostomy tube otorrhea 1R21DC019958-01A1
2016 Single Antigen Strategy for Prevention of Recurrent and Chronic Suppurative Otitis 5R21DC014323-02
2015 Single Antigen Strategy for Prevention of Recurrent and Chronic Suppurative Otitis 1R21DC014323-01A1
2007 RANDOMIZED TRIAL OF THE SAFETY AND IMMUNOGENICITY OF FLUMIST IN HIV INF CHILDREN 2M01RR000533-39-8164 503
2007 SAFETY AND IMMUNOGENICITY STUDY OF QUADRIVALENT HUMAN PAPILLOMAVIRUS 2M01RR000533-39-8202 503
2007 LATE OUTCOMES OF PEDIATRIC HIV INFECTION (PACTG 219C VERSION 40) 2M01RR000533-39-8205 503
2006 ULTRASOUND EVAL OF FLOW RELATED ARTERIAL DILATION IN HIV INFECTED CHILDREN 5M01RR000533-38-5588 503
2006 RANDOMIZED TRIAL OF THE SAFETY AND IMMUNOGENICITY OF FLUMIST IN HIV INF CHILDREN 5M01RR000533-38-5614 503
2006 LATE OUTCOMES OF PEDIATRIC HIV INFECTION (PACTG 219C VERSION 40) 5M01RR000533-38-5633 503
Showing 10 of 48 results. Show All Results

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis       Copy PMIDs To Clipboard

  1. McGovern I, Chastek B, Bancroft T, Webb N, Imran M, Pelton SI, Haag MDM. Relative vaccine effectiveness of MF59®-adjuvanted vs high-dose trivalent inactivated influenza vaccines for prevention of test-confirmed influenza hospitalizations during the 2017-2020 influenza seasons. Int J Infect Dis. 2024 Jul 03; 107160. PMID: 38969330
     
  2. Fisman D, Giglio N, Levin MJ, Nguyen VH, Pelton SI, Postma M, Ruiz-Aragón J, Urueña A, Mould-Quevedo JF. The economic rationale for cell-based influenza vaccines in children and adults: A review of cost-effectiveness analyses. Hum Vaccin Immunother. 2024 Dec 31; 20(1):2351675. PMID: 38835218; PMCID: PMC11155702; DOI: 10.1080/21645515.2024.2351675;
     
  3. Hurst JH, Shaik-Dasthagirisaheb YB, Truong L, Boiditswe SC, Patel SM, Gilchrist J, Maciejewski J, Luinstra K, Smieja M, Steenhoff AP, Cunningham CK, Pelton SI, Kelly MS. Serotype epidemiology and antibiotic resistance of pneumococcal isolates colonizing infants in Botswana (2016-2019). PLoS One. 2024; 19(5):e0302400.View Related Profiles. PMID: 38787847; PMCID: PMC11125537; DOI: 10.1371/journal.pone.0302400;
     
  4. Yildirim I, Lapidot R, Shaik-Dasthagirisaheb YB, Hinderstein S, Lee H, Klevens M, Grant L, Arguedas Mohs AG, Cane A, Madoff L, Johnson H, Ivanof C, Burns M, Pelton S. Invasive Pneumococcal Disease After 2 Decades of Pneumococcal Conjugate Vaccine Use. Pediatrics. 2024 Jan 01; 153(1).View Related Profiles. PMID: 38087952
     
  5. Levin MJ, Divino V, Postma MJ, Pelton SI, Zhou Z, DeKoven M, Mould-Quevedo J. A clinical and economic assessment of adjuvanted trivalent versus standard egg-derived quadrivalent influenza vaccines among older adults in the United States during the 2018-19 and 2019-20 influenza seasons. Expert Rev Vaccines. 2024; 23(1):124-136. PMID: 38073493
     
  6. Pelton SI, Mould-Quevedo JF, Nguyen VH. Modelling the population-level benefits and cost-effectiveness of cell-based quadrivalent influenza vaccine for children and adolescents aged 6 months to 17 years in the US. Expert Rev Vaccines. 2024; 23(1):82-87. PMID: 38093415
     
  7. Pelton SI, Hullegie S, Leach AJ, Marchisio P, Marom T, Sabharwal V, Shaikh N, Tähtinen PA, Venekamp RP. ISOM 2023 Research Panel 5: Interventions- Vaccines and prevention, medical and surgical treatment, and impact of COVID-19 pandemic. Int J Pediatr Otorhinolaryngol. 2024 Jan; 176:111782.View Related Profiles. PMID: 38000342; PMCID: PMC10842145; DOI: 10.1016/j.ijporl.2023.111782;
     
  8. Mould-Quevedo JF, Pelton SI, Nguyen VH. Vaccine Effectiveness of Cell-Based Quadrivalent Influenza Vaccine in Children: A Narrative Review. Vaccines (Basel). 2023 Oct 15; 11(10). PMID: 37896996; PMCID: PMC10610859; DOI: 10.3390/vaccines11101594;
     
  9. Pelton SI, Mould-Quevedo JF, Nguyen VH. The Impact of Adjuvanted Influenza Vaccine on Disease Severity in the US: A Stochastic Model. Vaccines (Basel). 2023 Sep 26; 11(10). PMID: 37896929; PMCID: PMC10610929; DOI: 10.3390/vaccines11101525;
     
  10. Mason KM, Marsh RL, Pelton SI, Harvill ET. Editorial: Otitis media. Front Cell Infect Microbiol. 2022; 12:1063153. PMID: 36506022; PMCID: PMC9733949; DOI: 10.3389/fcimb.2022.1063153;
     
Showing 10 of 311 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 300 publications over 42 distinct years, with a maximum of 15 publications in 2010

YearPublications
19803
19813
19832
19842
19855
19885
19894
19903
19913
19925
19937
19944
19957
19963
19972
19984
199911
200011
20014
200211
20039
20044
200511
20066
20077
20089
200914
201015
201112
201213
201312
201414
20159
20166
201710
20186
20199
20208
202113
20225
20235
20244
Contact for Mentoring:

670 Albany St Biosquare III
Boston MA 02118
Google Map


Pelton's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
_
Media Mentions
_
Co-Authors
_
Similar People
_
Same Department